<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03351517</url>
  </required_header>
  <id_info>
    <org_study_id>T/IM-NF/Pharma/02/17</org_study_id>
    <nct_id>NCT03351517</nct_id>
  </id_info>
  <brief_title>Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty</brief_title>
  <official_title>Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty: A Randomized Double Blind Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, Bhubaneswar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, Bhubaneswar</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study intends to evaluate the efficacy of Tapentadol against placebo as a preemptive
      analgesic in the management of post-operative pain in the patiens undergoing total knee
      arthroplasty.

      The primary objective is to evaluate th epain score in visual analogue scale at various time
      points within 24 hours post operarively
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of Change of Pain score compared to plecebo by visual analogue scale</measure>
    <time_frame>24 hrs. post-operatively</time_frame>
    <description>All the subjects will be assessed for pain at various time points post-operatively by visual analogue scale(VAS)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Tapentadol arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose of 100 mg of extended release oral tapentadol will be administered 1 hour before surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A comparable placebo will be administered 1 hour before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tapentadol 100 MG</intervention_name>
    <description>100 mg of oral extended release tapentadol will be given to the patients undergoing total knee replacement surgery on spinal anesthesia to evaluate its efficacy in the management of post-operative pain.</description>
    <arm_group_label>Tapentadol arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>A matching placebo will be given to the patients undergoing total knee replacement surgery on spinal anesthesia to evaluate its efficacy in the management of post-operative pain.</description>
    <arm_group_label>Placebo arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of either sex undergoing elective tota knee replacement surgery

          -  Patients are capable to provide an informed consent

          -  Age 18-65 years

        Exclusion Criteria:

          -  Patients with Asthma, copd or any other respiratory disease

          -  Persistent nausea , vomiting at the time of randomization

          -  Treated with MAO inhibitors, Tricyclic antidepressants, SSRIs and SNRIs

          -  Patients with ASA grading 3 or more

          -  Drug abuse history, opioid tolerance or dependence, known history of opiod allergies

          -  Renal or liver disease

          -  Major psychiatric disorder

          -  Pregnancy and lactation

          -  Emergency surgery

          -  Bone tumor, epilepsy or patients with migraine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DEBASISH HOTA, MD,DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>AIIMS Bhubaneswar</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DEBASISH HOTA, MD,DM</last_name>
    <phone>9438884190</phone>
    <email>debhota@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ANAND SRINIVASAN, MD,DM</last_name>
    <phone>9216996577</phone>
    <email>anandsrinivasan@aiimsbhubaneswar.edu.in</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>Bhubaneswar</city>
        <state>Odisha</state>
        <zip>751019</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anand Srinivasan, M.D.,D.M.</last_name>
      <phone>00919216996577</phone>
    </contact>
    <investigator>
      <last_name>Debasish Hota, M.D.,D.M.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2017</study_first_submitted>
  <study_first_submitted_qc>November 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, Bhubaneswar</investigator_affiliation>
    <investigator_full_name>Dr Debasish Hota</investigator_full_name>
    <investigator_title>Prof and Head of the Department</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

